The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Prevention of NSAID-induced gastroduodenal ulcers
Open accessAbstract
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are important agents in the management of arthritic and inflammatory conditions, and are among the most frequently prescribed medications in North America and Europe. However, there is overwhelming evidence linking these agents to a variety of gastrointestinal (GI) toxicities. OBJECTIVES: To review the effectiveness of common interventions for the prevention of NSAID induced upper GI toxicity. SEARCH STRATEGY: A literature search was conducted, according to the Cochrane methodology for identification of randomized controlled trials in electronic databases, including MEDLINE from 1966 to January 2000, Current Contents for 6 months prior to January 2000, Embase to Febuary 1999, and a search of the Cochrane Controlled Trials Register from 1973 to 1999. Recent conference proceedings were reviewed and content experts and companies were contacted. SELECTION CRITERIA: Randomized controlled clinical trials (RCTs) of prostaglandin analogues (PA), H2-receptor antagonists (H2RA) or proton pump inhibitors (PPI) for the prevention of chronic NSAID induced upper GI toxicity were included. DATA COLLECTION AND ANALYSIS: Two independent reviewers extracted data regarding population characteristics, study design, methodological quality and number of patients with endoscopic ulcers, ulcer complications, symptoms, overall drop-outs, drop outs due to symptoms. Dichotomous data was pooled using Revman V3.1. Heterogeneity was evaluated using a chi square test. MAIN RESULTS: Thirty-three RCTs met the inclusion criteria. All doses of misoprostol significantly reduced the risk of endoscopic ulcers. Misoprostol 800 ug/day was superior to 400 ug/day for the prevention of endoscopic gastric ulcers (RR=0.18, and RR=0.38 respectively, p=0.0055). A dose response relationship was not seen with duodenal ulcers. Misoprostol caused diarrhea at all doses, although significantly more at 800ug/day than 400ug/day (p=0.0012). Misoprostol was the only prophylactic agent documented to reduce ulcer complications. Standard doses of H2RAs were effective at reducing the risk of endoscopic duodenal (RR=0.24; 95% CI: 0.10-0.57) but not gastric ulcers(RR=0.73; 95% CI:0.50-1.09). Both double dose H2RAs and PPIs were effective at reducing the risk of endoscopic duodenal and gastric ulcers (RR=0.44; 95% CI:0.26-0.74 and RR=0.37;95% CI;0.27-0.51 respectively for gastric ulcer), and were better tolerated than misoprostol. REVIEWER'S CONCLUSIONS: Misoprostol, PPIs, and double dose H2RAs are effective at preventing chronic NSAID related endoscopic gastric and duodenal ulcers. Lower doses of misoprostol are less effective and are still associated with diarrhea. Only Misoprostol 800ug/day has been directly shown to reduce the risk of ulcer complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
The file drawer problem and tolerance for null results.
Rosenthal, R. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.3.638 · Cited by 9,068
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Kearney, P. M., Baigent, C., Godwin, J., Halls, H., Emberson, J. R., & Patrono, C. (2006) · BMJ · doi:10.1136/bmj.332.7553.1302 · Cited by 1,445
Meta-Analysis in Clinical Research
L'ABBÉ, K. A., DETSKY, A. S., & O'ROURKE, K. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-224 · Cited by 1,267
Gabriel, S. E., Jaakkimainen, L., & Bombardier, C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-10-787 · Cited by 1,237
Silverstein, F. E., Graham, D. Y., Senior, J. R., Davies, H. W., Struthers, B. J., Bittman, R. M., & Geis, G. S. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-4-199508150-00001 · Cited by 1,059
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
Langman, M. J. S., Weil, J., Wainwright, P., Lawson, D. H., Rawlins, M. D., Logan, R. F. A., Murphy, M., Vessey, M. P., & Colin-Jones, D. G. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90185-6 · Cited by 872
Cited by
Jordan, K. M., Arden, N. K., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis, P., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011742 · Cited by 2,048
Pharmacological Management of Persistent Pain in Older Persons
American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02376.x · Cited by 1,008
A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly
Wongrakpanich, S., Wongrakpanich, A., Melhado, K., & Rangaswami, J. (2018) · Aging and disease · doi:10.14336/ad.2017.0306 · Cited by 917
Pharmacological Management of Persistent Pain in Older Persons
(2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00699.x · Cited by 916
Management of Patients With Ulcer Bleeding
Laine, L., & Jensen, D. M. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.480 · Cited by 807
Guidelines for Prevention of NSAID-Related Ulcer Complications
and the Practice Parameters Committee of the American College of Gastroenterology, Lanza, F. L., Chan, F. K. L., & Quigley, E. M. M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.115 · Cited by 790
Gastric Mucosal Defense and Cytoprotection: Bench to Bedside
Laine, L., Takeuchi, K., & Tarnawski, A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.030 · Cited by 767
Sostres, C., Gargallo, C. J., Arroyo, M. T., & Lanas, A. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2009.11.005 · Cited by 685
Self-citationSystematic review of the risk of enteric infection in patients taking acid suppression
Leonard, J., Marshall, J. K., & Moayyedi, P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01275.x · Cited by 633
External Validation of a Measurement Tool to Assess Systematic Reviews (AMSTAR)
Shea, B. J., Bouter, L. M., Peterson, J., Boers, M., Andersson, N., Ortiz, Z., Ramsay, T., Bai, A., Shukla, V. K., & Grimshaw, J. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001350 · Cited by 569
“The topics of the reviews ranged across the spectrum of GI problems like dyspepsia, gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), and also GI drug interventions such as H2 receptor antagonists and proton pump inhibitors [9–50].”
BackgroundAdvances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology
Altman, R., Bosch, B., Brune, K., Patrignani, P., & Young, C. (2015) · Drugs · doi:10.1007/s40265-015-0392-z · Cited by 493
Writing Committee Members, Abraham, N. S., Hlatky, M. A., Antman, E. M., Bhatt, D. L., Bjorkman, D. J., Clark, C. B., Furberg, C. D., Johnson, D. A., Kahi, C. J., et al. (2010) · Circulation · doi:10.1161/cir.0b013e318202f701 · Cited by 451
Strategies toward rheumatoid arthritis therapy; the old and the new
Abbasi, M., Mousavi, M. J., Jamalzehi, S., Alimohammadi, R., Bezvan, M. H., Mohammadi, H., & Aslani, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27860 · Cited by 443
American Gastroenterological Association Technical Review on the Evaluation of Dyspepsia
Talley, N. J., Vakil, N. B., & Moayyedi, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.020 · Cited by 440
Hoes, J. N., Jacobs, J. W. G., Boers, M., Boumpas, D., Buttgereit, F., Caeyers, N., Choy, E. H., Cutolo, M., Da Silva, J. A. P., Esselens, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.072157 · Cited by 411
Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention
Vonkeman, H. E., & van de Laar, M. A. F. J. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.08.001 · Cited by 365
Rostom, A., Dubé, C., Lewin, G., Tsertsvadze, A., Barrowman, N., Code, C., Sampson, M., & Moher, D. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00010 · Cited by 343
Self-citationThiazole Ring—A Biologically Active Scaffold
Petrou, A., Fesatidou, M., & Geronikaki, A. (2021) · Molecules · doi:10.3390/molecules26113166 · Cited by 343
Chen, Y., Jobanputra, P., Barton, P., Bryan, S., Fry-Smith, A., Harris, G., & Taylor, R. (2008) · Health Technology Assessment · doi:10.3310/hta12110 · Cited by 339
Developments in the clinical understanding of osteoarthritis
Felson, D. T. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2531 · Cited by 338
Dubé, C., Rostom, A., Lewin, G., Tsertsvadze, A., Barrowman, N., Code, C., Sampson, M., & Moher, D. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00009 · Cited by 334
Self-citationLanas, A., García-Rodríguez, L. A., Arroyo, M. T., Bujanda, L., Gomollón, F., Forné, M., Aleman, S., Nicolas, D., Feu, F., González-Pérez, A., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01062.x · Cited by 298
Self-citationThe appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal
Savarino, V., Dulbecco, P., de Bortoli, N., Ottonello, A., & Savarino, E. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.10.007 · Cited by 270
Scally, B., Emberson, J. R., Spata, E., Reith, C., Davies, K., Halls, H., Holland, L., Wilson, K., Bhala, N., Hawkey, C., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30037-2 · Cited by 259
Anglin, R., Yuan, Y., Moayyedi, P., Tse, F., Armstrong, D., & Leontiadis, G. I. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.82 · Cited by 234
Health information exchange and patient safety
Kaelber, D. C., & Bates, D. W. (2007) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2007.08.011 · Cited by 206
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions
Song, H., Zhu, J., & Lu, D. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010623.pub2 · Cited by 132
Acid Suppression Therapy: Where Do We Go from Here?
Scarpignato, C., Pelosini, I., & Di Mario, F. (2006) · Digestive Diseases · doi:10.1159/000091298 · Cited by 119
Gwee, K.-A., Goh, V., Lima, G., & Setia, S. (2018) · Journal of Pain Research · doi:10.2147/jpr.s156938 · Cited by 117
Katz, J. N., Smith, S. R., Collins, J. E., Solomon, D. H., Jordan, J. M., Hunter, D. J., Suter, L. G., Yelin, E., Paltiel, A. D., & Losina, E. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.10.006 · Cited by 83
SSRIs and gastrointestinal bleeding
Paton, C., & Ferrier, I. N. (2005) · BMJ · doi:10.1136/bmj.331.7516.529 · Cited by 81
Toxicological Property of Acetaminophen: The Dark Side of a Safe Antipyretic/Analgesic Drug?
Ishitsuka, Y., Kondo, Y., & Kadowaki, D. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00722 · Cited by 63
Zhu, T.-H., Zou, G., Ding, S.-J., Li, T.-T., Zhu, L.-B., Wang, J.-Z., Yao, Y.-X., & Zhang, X.-M. (2019) · Journal of Pain Research · doi:10.2147/jpr.s195909 · Cited by 43
Metadata
- Authors
- Rostom, A., Dube, C., Wells, G. A., Tugwell, P., Welch, V., Jolicoeur, E., McGowan, J., Lanas, A., Rushton, E., & Shukla, T.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2002-10-21
- Volume
- 2021
- Issue
- 10
- Pages
- CD002296-CD002296
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1489584806
- Cited by
- 470
- References
- 52
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.